1.
Adelusi TI, Abdul-Hammed M, Ojo EM, et al. Molecular Docking Assessment of Clinically Approved Antiviral Drugs against Mpro, Spike Glycoprotein and Angiotensin Converting Enzyme-2 Revealed Probable Anti-SARS-CoV-2 Potential: doi.org/10.26538/tjnpr/v5i4.30. TJNPR. 2021;5(4):778-791. Accessed November 25, 2024. https://tjnpr.org/index.php/home/article/view/677